- Additional Public Comment Opportunities
Current Public Comment Opportunities
Click the arrow for each public comment opportunity to learn how to provide comments.
- Timely Follow-up on Abnormal Screening Mammograms for Breast Cancer Detection
Project Title: Timely Follow-up on Abnormal Screening Mammograms for Breast Cancer Detection
Dates:
The Call for Public Comment period opens on October 1, 2024 and closes on October 15, 2024.
Project Overview:
The Gordon and Betty Moore Foundation funded Brigham and Women’s Hospital to develop an electronic Clinical Quality Measure (eCQM) to report on timely follow-up on abnormal screening mammograms for breast cancer detection. As part of its measure development process, Brigham and Women’s Hospital requests interested parties to submit comments on the proposed specifications for this measure. In brief, this eCQM reports the percentage of female patients aged 40 to 75 years with at least one abnormal screening mammogram who received either follow-up imaging with negative/benign results or a diagnostic sample extraction procedure (such as a biopsy) within 60 days after their first abnormal screening mammogram in the calendar year.
Documents and Measures for Comment:
You may access each document in the list by selecting its title:
Project-Specific Instructions:
Send your comments to asyrowatka@bwh.harvard.edu.
- Timely Follow-up on Positive Stool-based Screening Tests for Colorectal Cancer Detection
Project Title: Timely Follow-up on Positive Stool-based Screening Tests for Colorectal Cancer Detection
Dates:
The Call for Public Comment period opens on October 1, 2024 and closes on October 15, 2024.
Project Overview:
The Gordon and Betty Moore Foundation funded Brigham and Women’s Hospital to develop an electronic Clinical Quality Measure (eCQM) to report on timely follow-up on positive stool-based screening tests for colorectal cancer detection. As part of its measure development process, Brigham and Women’s Hospital requests interested parties to submit comments on the proposed specifications for this measure. In brief, this eCQM reports the percentage of patients aged 45 to 75 years with at least one positive stool-based colorectal cancer screening test (i.e., high-sensitivity guaiac fecal occult blood test, fecal immunochemical test, or Cologuard) who completed a colonoscopy within 180 days after their first positive stool-based test result date in the calendar year.
Documents and Measures for Comment:
You may access each document in the list by selecting its title:
Project-Specific Instructions:
Send your comments to asyrowatka@bwh.harvard.edu.
Content by non-CMS entities is provided for informational purposes only; inclusion on the CMS MMS Hub does not constitute endorsement or approval by CMS of any products, services, or opinions of the corporation, organization, or individual. CMS bears no responsibility for the accuracy, legality, or content produced by non-CMS entities. Contact the external entity with questions about its content.
Last Updated: